Clinical Trial

Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this prospective, nonrandomized controlled phase IV study is to compare standard and advanced MRI for their ability to predict response to Optune therapy.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-01-01 -> 2026-12-31 2026-07-31
minor Completion pushed: 2026-01-01 -> 2026-12-31 2026-07-31
Trial Details
NCT Number NCT03297125
Lead Sponsor Medical College of Wisconsin
Conditions Glioblastoma
Enrollment 60 participants
Start Date 2017-12-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30